65,437 trials
Symptomatic Paroxysmal Atrial Fibrillation (PAF)
Primary: Number of Subjects With Recurrence of Atrial Arrhythmias or Prescription of Anti-arrhythmic Drug or Re-ablation After a Blanking Period of Three Months After the Initial…
Electronic Fetal Monitoring · Fetal Hypoxia · Fetal-Placental Circulation
Primary: Mean Umbilical Artery Lactate at Delivery — 3.5; 3.4 mmol/L — p=0.69
Esophageal Cancer · Gastric Cancer
Primary: Percentage of Participants With Objective Response Assessed by Independent Review Committee — 31; 58 percentage of participants
Type 1 Diabetes Mellitus
Primary: Efficacy of Pramlintide by Measurement of 24-hour Tissue Mean Weighted Glucose (MWG) Obtained With Continuous Glucose Monitoring (CGM) — 173.8; 152.2 mg/dL — p=0.0118
Pregnancy
Primary: Consumer Agreement — 100 percentage of agreement
Neoplasms
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious Adverse Events (SAEs) — 4; 4; 4; 4 Participants
Rheumatoid Arthritis
Primary: Change From Baseline in Disease Activity Score Based on 28-joints Count and Erythrocyte Sedimentation Rate (DAS28-ESR) at Week 24 — 5.80; -3.07 units on a scale
Vitamin D Deficiency · Pre-Eclampsia
Primary: Number of Participants With Pre-eclampsia in Both Arms — 6; 1 Participants — p=<0.05
Diabetes Mellitus, Type 1
Primary: Change From Baseline in Glycated Hemoglobin (HbA1c) at Week 26 for Full Analysis Set (FAS) (Observed Cases [OC]) — 0.20; -0.09; -0.25; -0.33 Percentage (%) — p=<0.0001
Atrial Fibrillation
Primary: Clinically Relevant Bleeding — 367; 668; 635; 767 participants with event — p=<0.0001
Primary Progressive Multiple Sclerosis
Primary: Percent Brain Volume Change (PBVC) From Baseline to Week 48 Using a Repeated Measures ANCOVA Model — -0.454; -0.438 percentage change from baseline — p=0.903
HIV-1 Infection
Primary: Percentage of Participants With HIV-1 RNA ≥ 50 Copies/mL at Week 48 as Determined by the US FDA-Defined Snapshot Algorithm — 1.7; 1.7 percentage of participants — p=1.00
Diabetes Mellitus
Primary: Evidence for Improved Diabetic Care With Mobile Phone Application Use — 2; 0 Participants
Normal Pressure Hydrocephalus
Primary: Tinetti Score on Open Shunt vs. Closed Shunt — 24.50; 26.50 score on a scale
Diabetic Retinopathy
Primary: Change in Dark Adaptation, Rod Intercept — 0.3; -0.3 minutes — p=.70